Literature DB >> 8890037

Viral serologies in patients with chronic fatigue and chronic fatigue syndrome.

D Buchwald1, R L Ashley, T Pearlman, P Kith, A L Komaroff.   

Abstract

Chronic fatigue syndrome (CFS) is an illness characterized by disabling fatigue associated with complaints of fevers, sore throat, myalgia, lymphadenopathy, sleep disturbances, neurocognitive difficulties, and depression. A striking feature of CFS is its sudden onset following an acute, presumably viral, illness and the subsequent recurrent "flu-like" symptoms. It has been speculated that both CFS and debilitating chronic fatigue (CF) that does not meet strict criteria for CFS may be the direct or indirect result of viral infections. We therefore tested 548 chronically fatigued patients who underwent a comprehensive medical and psychiatric evaluation for antibodies to 13 viruses. Our objectives were to compare the seroprevalence and/or geometric mean titer (GMT) of antibodies to herpes simplex virus 1 and 2, rubella, adenovirus, human herpesvirus 6, Epstein-Barr virus, cytomegalovirus, and Cox-sackie B virus, types 1-6 in patients with CF to healthy control subjects. Other goals were to determine if greater rates of seropositivity or higher GMTs occurred among subsets of patients with CFS, fibromyalgia, psychiatric disorders, a self-reported illness onset with a viral syndrome, and a documented temperature > 37 degrees C on physical examination. Differences in the seroprevalence or GMTs of antibodies to 13 viruses were not consistently found in those with CF compared with control subjects, or in any subsets of patients including those with CFS, an acute onset of illness, or a documented fever. These particular viral serologies were not useful in evaluating patients presenting with CF.

Entities:  

Mesh:

Year:  1996        PMID: 8890037     DOI: 10.1002/(SICI)1096-9071(199609)50:1<25::AID-JMV6>3.0.CO;2-V

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Human herpesviruses in chronic fatigue syndrome.

Authors:  H L Wallace; B Natelson; W Gause; J Hay
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

3.  GB virus-C--a virus without a disease: we cannot give it chronic fatigue syndrome.

Authors:  James F Jones; Prasad S Kulkarni; Salvatore T Butera; William C Reeves
Journal:  BMC Infect Dis       Date:  2005-09-28       Impact factor: 3.090

4.  The association between herpes virus infections and functional somatic symptoms in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Robert Schoevers; Hans Klein; Judith Rosmalen
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

Review 5.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

6.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 7.  The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

Authors:  Adam J O'Neal; Maureen R Hanson
Journal:  Front Med (Lausanne)       Date:  2021-06-18

8.  Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects.

Authors:  Suzanne D Vernon; Sanjay K Shukla; Jennifer Conradt; Elizabeth R Unger; William C Reeves
Journal:  BMC Microbiol       Date:  2002-12-23       Impact factor: 3.605

9.  Commentary: Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Maria Eugenia Ariza
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

Review 10.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.